For sites that are already fatigued by tech, short-staffed, and buried up to their eyes in work, lab-specific e-reqs only increase operational burden.

Not only are these solutions inflexible with site-specific SOPs for sample management and metadata capture, but they often require sites to perform additional work that doesn’t integrate well into their pre-existing workflows.Sponsors should prioritize solutions that put sites first and make their lives easier.

Because of the complex needs of precision medicine, most studies are supported by several labs that operate in siloes.
‍
Lab-specific e-reqs do nothing to connect the clinical trial ecosystem, which is something that today’s clinical research landscape demands.

Requisition forms might seem like the only way to transmit data to labs, but these solutions hinder sample tracking, exacerbate data reconciliation, and impede data insights that can be gleaned from the complete picture of your sample metadata.
‍
ICH E6(R3) also mandates that biospecimens be part of the essential study record, subjecting them to robust data governance requirements. If sponsors lack a robust audit trail of every aspect of sample management — from collection to destruction — it’s nearly impossible to validate biospecimen data integrity. Lab-specific e-reqs do not address this fundamental process gap.